172 related articles for article (PubMed ID: 37151384)
21. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
22. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress.
Kim NH; Cha YH; Lee J; Lee SH; Yang JH; Yun JS; Cho ES; Zhang X; Nam M; Kim N; Yuk YS; Cha SY; Lee Y; Ryu JK; Park S; Cheong JH; Kang SW; Kim SY; Hwang GS; Yook JI; Kim HS
Nat Commun; 2017 Feb; 8():14374. PubMed ID: 28176759
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA GAS5 inhibits cell proliferation, induces G0/G1 arrest and apoptosis, and functions as a prognostic marker in colorectal cancer.
Yang Y; Shen Z; Yan Y; Wang B; Zhang J; Shen C; Li T; Ye C; Gao Z; Peng G; Ye Y; Jiang K; Wang S
Oncol Lett; 2017 May; 13(5):3151-3158. PubMed ID: 28521420
[TBL] [Abstract][Full Text] [Related]
24. Long Noncoding RNA LOC550643 Acts as an Oncogene in the Growth Regulation of Colorectal Cancer Cells.
Wu HF; Lu TJ; Lo YH; Tu YT; Chen YR; Lee MC; Chiang YL; Yeh CY; Tsai KW
Cells; 2022 Mar; 11(7):. PubMed ID: 35406629
[TBL] [Abstract][Full Text] [Related]
25. PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer
Deng L; Zhao Y; Liu W
J Chemother; 2023 Dec; ():1-13. PubMed ID: 38044588
[TBL] [Abstract][Full Text] [Related]
26. Wnt signaling promotes tumor development in part through phosphofructokinase 1 platelet isoform upregulation.
Jeon SM; Lim JS; Park SH; Lee JH
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34515327
[TBL] [Abstract][Full Text] [Related]
27. PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer.
Peng J; Li P; Li Y; Quan J; Yao Y; Duan J; Liu X; Li H; Yuan D; Wang X
Sci Rep; 2023 Oct; 13(1):17399. PubMed ID: 37833332
[TBL] [Abstract][Full Text] [Related]
28. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
Ren H; Chen Z; Yang L; Xiong W; Yang H; Xu K; Zhai E; Ding L; He Y; Song X
Cancer Manag Res; 2019; 11():4917-4930. PubMed ID: 31213910
[No Abstract] [Full Text] [Related]
30. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
Chen L; Hu N; Wang C; Zhao H
Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
[TBL] [Abstract][Full Text] [Related]
31. Silencing PFKP restrains the stemness of hepatocellular carcinoma cells.
Sha X; Wang K; Wang F; Zhang C; Yang L; Zhu X
Exp Cell Res; 2021 Oct; 407(1):112789. PubMed ID: 34418458
[TBL] [Abstract][Full Text] [Related]
32. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
33. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
34. GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer.
Zhao Z; Gao Y; Guan X; Liu Z; Jiang Z; Liu X; Lin H; Yang M; Li C; Yang R; Zou S; Wang X
Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30029519
[No Abstract] [Full Text] [Related]
35. PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.
Lang L; Chemmalakuzhy R; Shay C; Teng Y
Adv Exp Med Biol; 2019; 1134():243-258. PubMed ID: 30919341
[TBL] [Abstract][Full Text] [Related]
36. High PHD Finger Protein 19 (PHF19) expression predicts poor prognosis in colorectal cancer: a retrospective study.
Li P; Sun J; Ruan Y; Song L
PeerJ; 2021; 9():e11551. PubMed ID: 34141488
[TBL] [Abstract][Full Text] [Related]
37. PFKP: More than phosphofructokinase.
Wang H; Penaloza T; Manea AJ; Gao X
Adv Cancer Res; 2023; 160():1-15. PubMed ID: 37704285
[TBL] [Abstract][Full Text] [Related]
38. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
Liu L; Yang Y; Zhou X; Yan X; Wu Z
Biomed Pharmacother; 2018 Mar; 99():645-654. PubMed ID: 29653487
[TBL] [Abstract][Full Text] [Related]
39. PDRG1 predicts a poor prognosis and facilitates the proliferation and metastasis of colorectal cancer.
Xu Y; Liu J; Jiang T; Shi L; Shang L; Song J; Li L
Exp Cell Res; 2021 Dec; 409(2):112924. PubMed ID: 34780783
[TBL] [Abstract][Full Text] [Related]
40. PFKP confers chemoresistance by upregulating ABCC2 transporter in non-small cell lung cancer.
Wang Z; Wu S; Chen X; Liang J; Xue F; Cho WC; Bao J; Chen B; Ye M; Ma D; Zhu C; Zhu J; Shen J
Transl Lung Cancer Res; 2023 Nov; 12(11):2294-2309. PubMed ID: 38090515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
